Respiratory syncytial virus [virs]
hospitalisations [hlca]
Congenital heart disease [cgab, dsyn]
Congenital heart disease [cgab, dsyn]
Severe [qlco]
Respiratory syncytial virus [virs]
Young Child [aggp]
Based [ftcn]
Respiratory syncytial virus [virs]
hospitalisations [hlca]
Congenital heart disease [cgab, dsyn]
Patients [podg]
Needed [qlco]
Estimate [qnco]
Respiratory syncytial virus [virs]
immunoprophylaxis [topp]
palivizumab [aapp, imft, phsu]
Aims [idcn]
Obtain [ftcn]
Based [ftcn]
Respiratory syncytial virus [virs]
Hospitalization [hlca]
Children [aggp]
months [tmco]
Age [orga]
Congenital heart disease [cgab, dsyn]
{Non-patient} [clna]
Congenital heart disease [cgab, dsyn]
Previous [tmco]
Patients [podg]
Needed [qlco]
NNT [gngm]
palivizumab [aapp, imft, phsu]
PREVENT [phsu]
Respiratory syncytial virus [virs]
Hospitalization [hlca]
Methods [inpr]
Six [qnco]
Longitudinal [spco]
Population Based Study [resa]
Institution [hcro, mnob]
Sole [blor]
Provider [prog]
Primary [qlco]
Tertiary Care [hlca]
Defined [cnce]
paediatric [bmod]
Respiratory syncytial virus [virs]
Hospitalization [hlca]
Child [aggp]
Congenital heart disease [cgab, dsyn]
Patients [podg]
Aged [orga]
months [tmco]
Age [orga]
2 5 [qnco]
5 6 [fndg]
2-3 [resa]
Relative Risk [qnco]
Comparison [acty]
{Non-patient} [clna]
Congenital heart disease [cgab, dsyn]
NNT [gngm]
Various [irda]
Age Groups [aggp]
Respiratory syncytial virus [virs]
Hospitalization [hlca]
Congenital heart disease [cgab, dsyn]
Patients [podg]
Reported [inpr]
USA [geoa]
Based [ftcn]
Relative Risk [qnco]
palivizumab [aapp, imft, phsu]
APPEAR [qlco]
justify [ftcn]
Study [mnob]
Area [geoa]
